BUDGET IMPACT ANALYSIS OF AN ETANERCEPT BIOSIMILAR FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN EUROPE

被引：0
|
作者：
Ruff, L. [1 ]
Rezk, M. F. [2 ]
Uhlig, T. [3 ]
Gommers, J. W. [2 ]
机构：
[1] Covance Inc, London, England
[2] Biogen Int GmbH, Zug, Switzerland
[3] Diakonhjemmet Hosp, Oslo, Norway
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS31
引用
收藏
页码：A639 / A639
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT ANALYSIS OF AN ETANERCEPT BIOSIMILAR FOR THE TREATMENT OF ALL LICENSED ETANERCEPT INDICATIONS FOR ADULTS IN EUROPE
    Ruff, L.
    Rezk, M. F.
    Uhlig, T.
    Gommers, J. W.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A639 - A639
  • [2] IMPACT OF ETANERCEPT BIOSIMILAR LAUNCHES ON HEALTHCARE SPENDING: A UK BUDGET IMPACT MODEL FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND CHRONIC PLAQUE PSORIASIS
    Bhattacharyya, S.
    Banerjee, S.
    Clinton, H.
    Faithfull, G.
    Mendoza, C.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A580 - A581
  • [3] BUDGET IMPACT ANALYSIS OF TO CILIZUMAB, INFLIXIMAB AND ETANERCEPT DRUGS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN ECUADOR
    Briceno, V
    Naranjo, R.
    Moscoso, J. D.
    Salazar, D.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A937 - A937
  • [4] Budget impact analysis of the etanercept biosimilar: the Italian scenario
    Ravasio, Roberto
    Girolomoni, Giampiero
    Gorla, Roberto
    [J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2018,
  • [5] BUDGET IMPACT ANALYSIS OF BIOSIMILAR INFLIXIMAB TREATMENT FOR RHEUMATOID ARTHRITIS IN SIX CENTRAL EUROPEAN COUNTRIES
    Brodszky, V
    Pentek, M.
    Baji, P.
    Balogh, O.
    Hever N, V.
    Gulacsi, L.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A558 - A558
  • [6] LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis
    Song, Yeong Wook
    Park, Yong-Beom
    Kim, Jinseok
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 1 - 8
  • [7] The Budget Impact of a Biosimilar Transition Policy for Rheumatoid Arthritis Patients in Alberta
    Marshall, Deborah
    Currie, Gillian
    Lee, Raymond
    Kennedy, Bryanne
    Barber, Claire
    Twilt, Marinka
    Benseler, Susanne
    Brose, Andrea
    MacMullan, Paul
    Mosher, Dianne
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1113 - 1113
  • [8] Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
    Laura Chadwick
    Sizheng Zhao
    Eduardo Mysler
    Robert J. Moots
    [J]. Current Rheumatology Reports, 2018, 20
  • [9] Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
    Chadwick, Laura
    Zhao, Sizheng
    Mysler, Eduardo
    Moots, Robert J.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (12)
  • [10] 5 Year Budget Impact Analysis of Biosimilar Infliximab for the Treatment of Rheumatoid Arthritis in UK, Italy, France and Germany.
    Kim, JiSeon
    Hong, JungAn
    Kudrin, Alex
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S512 - S512
12345